High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

This publication has 31 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factor
  Atherosclerosis, 2001
• Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Treatment of Dyslipidemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• LDL Size and Risk of Coronary Heart Disease in Elderly Men and Women
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
  European Heart Journal, 1998
• Apolipoprotein B and Coronary Artery Disease in Women
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
  Circulation, 1998
• Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study
  Circulation, 1996
• The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995